Humacyte, Inc. Revenue Breakdown
No Revenue Breakdown for HUMA on this site yet.
- 2025-12-31: Others Not split by product in the filing$2.04M100.00%; Total revenue $2.04M.
- 2024-12-31: Total revenue $0.00.
Source checked: the stored Revenue Breakdown page for HUMA.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product in the filing $2.04M 100.00% | $2.04M |
| 2024-12-31 | $0.00 |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product $406.00K 100.00% | $406.00K |
| 2026-03-31 | Not split by product $495.00K 100.00% | $495.00K |
| 2025-12-31 | Not split by product $467.00K 100.00% | $467.00K |
| 2025-09-30 | Not split by product $753.00K 100.00% | $753.00K |
| 2025-06-30 | Not split by product $301.00K 100.00% | $301.00K |
| 2025-03-31 | Not split by product $517.00K 100.00% | $517.00K |
| 2024-12-31 | Not split by product $0.00 | $0.00 |
| 2024-09-30 | Not split by product $0.00 | $0.00 |
| 2024-06-30 | Not split by product $0.00 | $0.00 |
| 2024-03-31 | Not split by product $0.00 | $0.00 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |